Latest News

Page 13 of 30« First...1112131415...2030...Last »

May 27, 2015

New Free Apps Are Making Life Easier

Posted in: Latest News

MD Support recently launched LowViz Guide, a free indoor way-finding app for attendees at low vision conferences. And now, Novartis Pharmaceuticals has announced development of two apps that will make perfect partners. In collaboration with AMD Alliance International, the company has developed two free applications called ViaOpta Navigator and ViaOpta Daily. ViaOpta Navigator is a
read more »

May 20, 2015

Summary of Research and Development – 2015

Posted in: Latest News, Research and Developments

by Dan Roberts (Also available in audiovisual format) INTRODUCTION This is my 10th annual summary of leading research and developments that have occurred during the past 12 months in the field of blindness and low vision. For more details about any of the reports, sources are provided. Many studies and clinical trials are moving ever
read more »

May 14, 2015

MD Support’s LowViz Guide Offers Gift of Sight

Posted in: Latest News, Research and Developments

For four days, Bill DeMaio could see through walls. And that’s really saying something, considering that he has no eyesight. Until May 10, 2015, Bill could find his way around an unfamiliar building only by either asking people for directions or hoping to find Braille signs. But then, on the first day of the 2015
read more »

May 7, 2015

L-DOPA May Slow Development of AMD

Posted in: Latest News, Research and Developments

The color (pigmentation) of the retina, or lack thereof, is thought to play a role in the development of age-related macular degeneration (AMD). The substance that provides pigmentation is melanin, and a precursor to the pigment melanin is called L-DOPA. Since L-DOPA converts into dopamine in the brain, it has been used as a treatment
read more »

May 5, 2015

Learn About Comprehensive Dilated Eye Exams

Posted in: Latest News

People of all ages should have their eyesight tested to keep their vision at its best. Children usually have vision screening in school or at their pediatrician’s office. Adults, however, may require more than vision screening. Even if your vision seems fine, the only way to know for sure that your eyes are healthy is
read more »

May 1, 2015

Stem Cell Therapy Shows Positive Results In Asian Patients

Posted in: Latest News, Research and Developments

Ocata Therapeutics, Inc. (now owned by Acucela) has announced positive results in four Asian patients who were treated with the company’s proprietary RPE stem cells. These new data support previously reported positive long-term safety and signs of visual improvement, as reported here in October 2014. The Korean study, published online in Stem Cell Reports, features
read more »

April 13, 2015

That All May Read

Posted in: Latest News

The National Library Service for the Blind and Physically Handicapped (NLS) provides books and magazines in Braille and talking-book formats to half a million US citizens who can’t read standard print because of visual or physical disabilities. A patron may choose to receive books free through the mail or download them from NLS’s Braille and
read more »

April 3, 2015

Phase 2 Stem Cell Trial To Be Initiated

Posted in: Latest News, Therapies, Treatments, and Procedures

Ocata Therapeutics, Inc. (now owned by Acucela) announced on March 31, 2015 that the company has completed dosing of its Phase 1/2 studies for dry age-related macular degeneration (AMD) and Stargardt’s Macular Degeneration (SMD). A total of 38 patients have been safely dosed. The 200,000 cell cohort, the highest level planned, was successfully completed, paving
read more »

March 31, 2015

All About Eyeglasses

Posted in: Daily Living, Eye Conditions, Latest News

For something so important, most people know very little about their eyeglasses. What do those abbreviations and numbers on the prescription mean? Why do my friend and I have the same prescription numbers, when my vision is so much worse? What does 20/20 mean? If my best vision without glasses is 20/200, am I legally
read more »

March 30, 2015

Encapsulated Cell Technology Could Replace Injections in Wet AMD Patients

Posted in: Latest News

Neurotech Pharmaceuticals, Inc. announced on March 30, 2015 that the FDA has approved a Phase 2 clinical study of NT-503 Encapsulated Cell Therapy (ECT) for the treatment of wet age-related macular degeneration (AMD). ECT is an intravitreal implant that is genetically engineered to produce the biologic anti-VEGF drug NT-503 for at least 2 years. ECT, therefore, acts like
read more »

Page 13 of 30« First...1112131415...2030...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann